MELISSA MORRISON: Open Payments
NPI 1356792410 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 10 payments from 7 companies in 2025. Trend: 2023 $1,614 · 2024 $739 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Braeburn Inc. | 2 | $44 |
| Indivior Inc. | 1 | $37 |
| ABBVIE INC. | 2 | $31 |
| Abbott Laboratories | 1 | $29 |
| Alkermes, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: INGREZZA, BRIXADI, SUBLOCADE, AVEIR, ARISTADA, Auvelity, MAVYRET, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
